The governments of Malawi and India have signed a Memorandum of Understanding (MoU) on pharmacopoeial cooperation.
The signing of the MoU on Friday at Kamuzu Palace was part of bilateral talks between His Excellency President Dr. Lazarus McCarthy Chakwera and his Indian counterpart President Smt. Droupadi Murmu. The Indian President is in Malawi for a three-day state visit.
Among key areas under the agreement is to enhance cooperation in pharmacopoeia standards, specifically promoting understanding of Indian Pharmacopoeia (IP) in regulatory frameworks, requirements, and processes, considering that a significant proportion of medicines consumed in Malawi are manufactured in India.
This collaboration will facilitate the exchange of information and documentation related to the development of analytical methods published in IP.
PMRA Board Chairperson Mrs. Frider Chimimba and Indian High Commissioner to Malawi Mr. S. Gopalakrishnan signed the MoU, representing the Pharmacy and Medicines Regulatory Authority (PMRA) and the Indian Pharmacopoeia Commission (IPC), respectively.
President Chakwera and President Droupadi Murmu witnessed the signing of the agreement.
The Pharmacy and Medicines Regulatory Authority (PMRA) is notifying stakeholders, clients and the general public of commencement of a baseline survey on public awareness of the Authority’s mandate and functions.
The survey will be conducted from 20th October to 8th November, 2024, covering all 28 districts of Malawi.
The primary objective of this survey is to establish a public awareness index (PAI) for the Authority. The findings will inform strategic communication initiatives, enhance transparency, and foster accountability, ultimately enabling PMRA to better serve the public’s needs and interests.
Read more about the survey here.
The Pharmacy and Medicines Regulatory Authority (PMRA) is notifying stakeholders, clients and the general public of commencement of a baseline survey on public awareness of the Authority’s mandate and functions.
The survey will be conducted from 20th October to 8th November, 2024, covering all 28 districts of Malawi.
The primary objective of this survey is to establish a public awareness index (PAI) for the Authority. The findings will inform strategic communication initiatives, enhance transparency, and foster accountability, ultimately enabling PMRA to better serve the public’s needs and interests.
Read more about the survey here.
The Pharmacy and Medicines Regulatory Authority (PMRA) hosted a two-day interface meeting with a section of magistrates from on Thursday to Friday at Chikho Hotel in Mponela, Dowa. The meeting aimed to reflect on the legal framework of the medicines regulatory system in Malawi and identify ways to enhance its effectiveness.
The Authority recognizes the judiciary as a vital partner in combating pharmaceutical crimes, including medicine theft, illegal possession of medicines, and the trafficking of falsified and substandard medicines.
By collaborating with the Judiciary, PMRA aims to ensure a more effective regulatory environment, discouraging non-compliance and promoting a healthier Malawi through assurance of quality, safe and efficacious medicines and allied substances.
PMRA is mandated by the PMRA Act, 2019 to ensure that medicines and allied substances that are used in the country are of acceptable quality, safe and efficacious.
The Pharmacy and Medicines Regulatory Authority (PMRA) is pleased to announce that the next registration examinations for Pharmacists, Pharmacy Technologists and Pharmacy Assistants will be administered as follows:
MZUZU | LILONGWE | BLANTYRE | |
Time | 08h00 | 08h00 | 08h00 |
Date (s) | 25th – 26th November, 2024 | 25th – 26th November, 2024 | 25th – 26th November, 2024 |
Venue | Grand Palace Hotel | Crossroads Hotel | Victoria Hotel |
Eligible candidates who are interested to sit for these examinations are requested to confirm to PMRA by submitting duly filled registration application form with all required documents not later than 17h00 of 2nd November, 2024.
Application forms for both new applicants as well as those resitting the examinations, can be accessed on PMRA website www.pmra.mw or directly from PMRA office’s reception.
For further information and/or clarification please contact PMRA on 0999 708 450 / 0881 790 993/0999379544 or email at info@pmra.mw.